Literature DB >> 18508967

IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis.

Madeline Murphy1, Neil G Docherty, Brenda Griffin, Jillian Howlin, Emmett McArdle, Ruth McMahon, Holger Schmid, Matthias Kretzler, Alejandra Droguett, Sergio Mezzano, Hugh R Brady, Fiona Furlong, Catherine Godson, Finian Martin.   

Abstract

Induced in high glucose-1 (IHG-1) is an evolutionarily conserved gene transcript upregulated by high extracellular glucose concentrations, but its function is unknown. Here, it is reported that the abundance of IHG-1 mRNA is nearly 10-fold higher in microdissected, tubule-rich renal biopsies from patients with diabetic nephropathy compared with control subjects. In the diabetic nephropathy specimens, in situ hybridization localized IHG-1 to tubular epithelial cells along with TGF-beta1 and activated Smad3, suggesting a possible role in the development of tubulointerstitial fibrosis. Supporting this possibility, IHG-1 mRNA and protein expression also increased with unilateral ureteral obstruction. In the HK-2 proximal tubule cell line, overexpression of IHG-1 increased TGF-beta1-stimulated expression of connective tissue growth factor and fibronectin. IHG-1 was found to amplify TGF-beta1-mediated transcriptional activity by increasing and prolonging phosphorylation of Smad3. Conversely, inhibition of endogenous IHG-1 with small interference RNA suppressed transcriptional responses to TGF-beta1. In summary, IHG-1, which increases in diabetic nephropathy, may enhance the actions of TGF-beta1 and contribute to the development of tubulointerstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508967      PMCID: PMC2518434          DOI: 10.1681/ASN.2007101080

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  49 in total

1.  Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application.

Authors:  Clemens D Cohen; Karin Frach; Detlef Schlöndorff; Matthias Kretzler
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

2.  High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly.

Authors:  Michael R Clarkson; Madeline Murphy; Sunil Gupta; Teresa Lambe; Harald S Mackenzie; Catherine Godson; Finian Martin; Hugh R Brady
Journal:  J Biol Chem       Date:  2002-01-09       Impact factor: 5.157

3.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Authors:  J Yang; Y Liu
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 4.  Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease.

Authors:  Richard J Lund; Matthew R Davies; Keith A Hruska
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-01       Impact factor: 2.894

5.  Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy.

Authors:  S A Mezzano; M A Droguett; M E Burgos; L G Ardiles; C A Aros; I Caorsi; J Egido
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

6.  Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease.

Authors:  S A Mezzano; M Barría; M A Droguett; M E Burgos; L G Ardiles; C Flores; J Egido
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

7.  Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

Authors:  K A Hruska; G Guo; M Wozniak; D Martin; S Miller; H Liapis; K Loveday; S Klahr; T K Sampath; J Morrissey
Journal:  Am J Physiol Renal Physiol       Date:  2000-07

8.  Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.

Authors:  W Xu; K Angelis; D Danielpour; M M Haddad; O Bischof; J Campisi; E Stavnezer; E E Medrano
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

9.  Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.

Authors:  Motohide Isono; Sheldon Chen; Soon Won Hong; M Carmen Iglesias-de la Cruz; Fuad N Ziyadeh
Journal:  Biochem Biophys Res Commun       Date:  2002-09-06       Impact factor: 3.575

Review 10.  Smad regulation in TGF-beta signal transduction.

Authors:  A Moustakas; S Souchelnytskyi; C H Heldin
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

View more
  20 in total

Review 1.  Doing it in reverse: 3'-to-5' polymerization by the Thg1 superfamily.

Authors:  Jane E Jackman; Jonatha M Gott; Michael W Gray
Journal:  RNA       Date:  2012-03-28       Impact factor: 4.942

Review 2.  Anti-fibrosis therapy and diabetic nephropathy.

Authors:  Anil Karihaloo
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

3.  Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy.

Authors:  Cuifang Wang; Bing He; Dongxu Piao; Ping Han
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

4.  Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.

Authors:  Lingyun Li; Nerimiah Emmett; David Mann; Xueying Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2010-03

5.  IHG-1 promotes mitochondrial biogenesis by stabilizing PGC-1α.

Authors:  Fionnuala B Hickey; James B Corcoran; Neil G Docherty; Brenda Griffin; Una Bhreathnach; Fiona Furlong; Finian Martin; Catherine Godson; Madeline Murphy
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

Review 6.  Gremlin: a complex molecule regulating wound healing and fibrosis.

Authors:  Steven O'Reilly
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

Review 7.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

Review 8.  Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?

Authors:  G C Higgins; M T Coughlan
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

9.  Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy.

Authors:  Li Qin Tang; Feng Ling Wang; Ling Na Zhu; Fei Lv; Sheng Liu; Shan Tang Zhang
Journal:  Mol Biol Rep       Date:  2012-12-25       Impact factor: 2.316

Review 10.  Excessively Enlarged Mitochondria in the Kidneys of Diabetic Nephropathy.

Authors:  Kiyoung Kim; Eun-Young Lee
Journal:  Antioxidants (Basel)       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.